1 |
Arefian H, Heublein S, Scherag A.Hospital-related cost of sepsis: A systematic review[J].J Infect,2017,74(2):107-117.
|
2 |
Lin JJ, Hsiao HJ, Chan OW, et al.Increased serum thrombomodulin level is assoc -iated with disease severity and mortality in pediatric sepsis[J].PLoS One,2017,12(8):e0182324.
|
3 |
Frencken JF, Van Vught LA, Peelen LM, et al.An Unbalanced Inflammatory Cyto kine Response Is Not Associated With Mortality Following Sepsis:A Prospective Cohort Study[J].Crit Care Med,2017,45(5):e493-e499.
|
4 |
Jia Y, Zhao Y, Li C, et al.The Expression of Programmed Death-1 on CD4+ and CD8+ T Lymphocytes in Patients with Type 2 Diabetes and Severe Sepsis[J].PLoS One,2016,11(7):e 0159383.
|
5 |
Strool I, Zeerleder S, Ding C, et al.Coagulation factor XI improves host defence during murine pneumonia-derived sepsis independent of factor XII activation[J].Thromb Haemost,2017,117(8):1601-1614.
|
6 |
Bone RC, Sibbald WJ, Sprung CL.The ACCP-SCCM consensus conference on sepsis and organ failure[J].Chest,1992,101(6):1481-1483.
|
7 |
Levy MM, Fink MP, Marshall JC, et al.2001SCCM/ESICM/ACCP/ATS/SIS Inte rnational Sepsis Definitions Conference[J].Intensive Care Med,2003,29(4):530-538.
|
8 |
Adhikari NK, Fowler RA, Bhagwanjee S, et al.Critical care and the global burden of critical illness in adults[J].Lancet,2010,376(9749):1339-1346.
|
9 |
Yealy DM, Kellum JA, Huang DT, et al.A randomized trial of protocol-based care for early septic shock[J].N Engl J Med,2014,370(18):1683-1693.
|
10 |
Singer M, Deutschman CS, Seymour CW, et al.The third international consensus definitions for sepsis and septic shock(Sepsis-3.0)[J].JAMA,2016,315(8):801-810.
|
11 |
Hotchkiss RS, Monneret G, Payen D.Sepsis-induced immunosuppression:from cellular dysfunctions to immunotherapy[J].Nat Rev Immunol,2013,13(12):862-874.
|
12 |
Czura CJ. "Merinoff symposium 2010:sepsis" -speaking with one voice[J].Mol Med,2011,17(1-2):2-3.
|
13 |
Nathan C, Cars O.Antibiotic resistance-problems,progress,and prospects[J].N Engl J Med, 2014,371(19):1761-1763.
|
14 |
Ferrer R, Martin-Loeches I, Phillips G, et al.Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour:results from a guideline-based performance improvement program[J].Crit Care Med,2014,42(8):1749-1755.
|
15 |
Kumar A, Roberts D, Wood KE, et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J].Crit Care Med,2006,34(6):1589-1596.
|
16 |
Clermont G, Angus DC, Linde-Zwirble WT, et al.Does acute organ dysfunction predict patient-centered outcomes [J].Chest,2002,121(6):1963-1971.
|
17 |
Hampson P, Dinsdale RJ, Wearn CM, et al.Neutrophil dysfunction,immature granulocytes,and cell-free DNA are early biomarkers of sepsis in burn-injured patients:a prosp ective observational cohort study[J].Ann Surg,2017,265(6):1241-1249.
|
18 |
Ge L, Hu Q, Chen J, et al.Inhibition of TNF-α sepsis of lipopolysaccharide induction using nano cerium oxide system[J].Mater Sci Eng C Mater Biol Appl,2017,1(77):405-410.
|
19 |
Kumar V.Dendritic cells in sepsis: Potential immunoregulatory cells with therapeutic potential [J].Mol Immunol,2018,9(101):615-626.
|
20 |
Ammer-Herrmenau C, Kulkarni U, Andreas N, et al.Sepsis induces long-lasting impairments in CD4+ T-cell responses despite rapid numerical recovery of T-lymphocyte populations[J].PLoS One,2019,14(2):e0211716.
|
21 |
Yadav H, Cartin-Ceba R.Balance between Hyperinflammation and Immunosuppression in Sepsis[J].Semin Respir Crit Care Med,2016,37(1):42-50.
|
22 |
Levi M, Poll TV.Coagulation in patients with severe sepsis[J].Semin Thromb Hemost,2015,41(1):9-15.
|
23 |
Tsao CM, Ho ST, Wu CC.Coagulation abnormalities in sepsis[J].Acta Anaesthesiol Taiwan,2015,53(1):16-22.
|
24 |
Earley ZM, Akhtar S, Green SJ, et al.Burn Injury Alters the Intestinal Microbio me and Increases Gut Permeability and Bacterial Translocation[J].PLoS One,2015,10(7):e0129996.
|
25 |
Shanahan F.99th Dahlem conference on infection,inflammation and chronic inflammatory disorders:host-microbe interactions in the gut:target for drug therapy, opportunity for drug discovery[J].Clin Exp Immunol,2010,160(1):92-97.
|
26 |
Heper Y, Akalin EH, Mistik R, et al.Evaluation of serum C-reactive protein,procalcitonin,tumor necrosis factor alpha,and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis,severe sepsis,and septic shock[J].Eur J Clin Microbiol,2006,25(8):481-491.
|
27 |
Harding D, Dhamrait S, Millar A, et al.Is interleukin-6-174 genotype associated with the devel -opment of septicemia in preterm infants? [J].Pediatrics,2003,112(4):800-803.
|
28 |
Dellinger RP, Levy MM, Carlet JM, et al.Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock:2008 [J].Crit Care Med,2008,36(1):296-327.
|
29 |
Paricahua LI, Goncalves AF, Pacheco SO, et al.Sepsis mortality in critical care and prior statin therapy:a retrospective cohort study in Central Argentina[J].J Clin Diaqn Res,2017,11(6):OC17-OC21.
|
30 |
Stolk RF, van der Poll T, Angus DC, et al.Potentially inadvertent immunomodulation:norepinephrine use in sepsis[J].Am J Respir Crit Care Med,2016,194(5):550-8.
|
31 |
Kalil AC, Sun J.Low-dose steroids for septic shock and severe sepsis:the use of Bayesian statistics to resolve clinical trial controversies[J].Intensive Care Med,2011,37(3):420-429.
|
32 |
Wu J, Zhou L, Liu J, et al.The efficacy of thymosin alpha 1 for severe sepsis (ETASS): a multicenter,single-blind, randomized and controlled trial[J].Crit Care,2013,17(1):R8.
|
33 |
Alejandria MM, Lansang MA, Dans LF, et al.Intravenous immunoglobulin for treating sepsis,severe sepsis and seotic shock[J].Cochrane Database Syst Rev,2013,16(9):CD001090.
|
34 |
Liu G, Ren W, Fang J.L-Glutamine and L-arginine protect against enterotoxigen ic Escherichia coli infection via intestinal innate immunity in mice[J].Amino Aci ds,2017,49(12):1945-1954.
|
35 |
Zampieri FG, Mazza B.Mechanical ventilation in sepsis:a reappraisal [J].Shock,2017,47(1S Suppl 1):41-46.
|
36 |
Grau T, Bonet A, Miñambres E.The effect of L-alang1-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients[J].Crit Care Med,2011,39(6):1263-1268.
|
37 |
于学忠,姚咏明,周荣斌.中国脓毒症/脓毒症休克急诊治疗指南(2018)[J].临床急诊杂志,2018,19(9):567-577.
|